| Code | 6011E | ||||||||||
| MA number | 31/0088/24-S | ||||||||||
| Product Form: | tbl flm 100x1x10 mg/40 mg (blis.OPA/Al/PVC/Al - jednotk.bal.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 14.05.2024 |
| Validity: | 14.05.2029 |
| SPC: |
SPC_Ezetimibe-Atorvastatin STADA tbl flm_06.2024.pdf
|
| PIL: |
PIL_Ezetimibe-Atorvastatin STADA tbl flm_08.2025.pdf
|
| Safety feature | Yes |
| Data update: | 17.05.2024 |
